SAN FRANCISCO, Sept. 23, 2025 /PRNewswire/ — Bunkerhill Health today announced it has received U.S. Food and Drug Administration (FDA) clearance for ECG-EF, an artificial intelligence algorithm that ...
Please provide your email address to receive an email when new articles are posted on . Finerenone reduced risk for CV death and worsening heart failure vs. placebo in this patient population. Pooled ...
Credit: Eko Health. The FDA clearance was based on data from a prospective clinical study of 3456 patients. The Food and Drug Administration (FDA) has cleared the Eko Low Ejection Fraction Tool (ELEFT ...
Heart failure with reduced ejection fraction (HFrEF) happens when the heart’s left ventricular ejection fraction (LVEF) is 40% or less, a sign of a weak heart pump. The problem is that this sign of ...
Javed Butler, MD, MPH, MBA, discusses the FINEARTS-HF trial presented at European Society of Cardiology Congress 2024, highlighting its objective to evaluate finerenone in patients with heart failure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results